Enzo Biochem settles class action for $7.5 million

Enzo Biochem Inc. (NYSE:ENZ), a medical laboratory services provider with a market capitalization of $36.6 million, has ...
Infosecurity-magazine.com

Enzo Biochem Hit by Ransomware, 2.5 Million Patients' Data Compromised

Enzo Biochem, a biotechnology company renowned for producing and distributing DNA-based tests designed to identify viral and bacterial diseases, has recently confirmed in a filing with the Securities ...
Hosted on MSN

Here’s Why Enzo Biochem (ENZ) Declined in Q4

Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Kingdom Capital Advisors is in its third year of ...
Seeking Alpha

ENZB Enzo Biochem, Inc.

A high-level overview of Enzo Biochem, Inc. (ENZB) stock. View (ENZB) real-time stock price, chart, news, analysis, analyst reviews and more.
Seeking Alpha

Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall

Enzo Biochem (NYSE: ENZ) announced its intention to voluntarily delist its common stock from The New York Stock Exchange and to have its common stock quoted on the OTCQX Best Market. Enzo provided ...
Nasdaq

Sirona Biochem Initiates Private Placement

VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the "Company") is pleased to announce a non-brokered private placement of up to ...